Task: Answer the multiple choice question.
Query: Which compound exhibits a -0.151% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Fc1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1
b) Cc1cc(NC(=O)[C@H](C)NC(=O)c2ccco2)ccc1Br
c) O=C(NCC(=O)N1CCOCC1)c1ccc(Br)cc1
Answer: c. O=C(NCC(=O)N1CCOCC1)c1ccc(Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCC(=O)N1CCOCC1)c1ccc(Br)cc1
O=C(NCC(=O)N1CCOCC1)c1ccc(Br)cc1
4-bromo-N-(2-morpholin-4-yl-2-oxoethyl)benzamide